The study, published April 4 in JAMA, analyzed National Health Interview Survey data from 110,283 adults and 30,708 youths from the 2019 to 2022 cycles.
Among youths, the prevalence of Type 1 diabetes was 3.5 per 1,000, with the highest rates among those aged 10 to 17, males, Hispanic youths and white participants.
Among adults, the prevalence of Type 1 diabetes was 5.3 per 1,000. The highest prevalence was among those 45 to 64, and 65 and older, Black and white participants.
“Consistent with the study results, emerging evidence suggests a high prevalence of type 1 diabetes among middle-aged and older adults,” the study authors wrote. “However, data on these populations remain sparse. Clinical guidance is often extrapolated from studies of younger populations with type 1 diabetes or adults with type 2 diabetes.” More research is needed to improve cardiovascular and glycemic control care in this population and for both adults and youths in racial and ethnic groups who may have difficulty accessing care, the authors wrote.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
